Security key
05464T104
Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 37,608,367
- Total 13F value
- $6,859,715,837
- Share change
- -670,066
- Put/Call ratio
- 66%
- SEC-reported price per share
- $182.64
- Number of holders
- 398
- Value change
- +$12,741,708
- Number of buys
- 204
- Number of sells
- 157
- Shares outstanding
- 51,632,132
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
398
Top holders
10
AXSM full security history
Ownership snapshot
Full 13F holder table
Axsome Therapeutics, Inc. SEC filings
Axsome Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 3.1%
13D/G row: RTW INVESTMENTS, LP
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 3.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
3.1%
VANGUARD GROUP INC
8.1%
BlackRock, Inc.
7.3%
WELLINGTON MANAGEMENT GROUP LLP
2.6%
MACQUARIE GROUP LTD
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13D/G
13F
Company
|
3.1%
|
$165,312,089
1,516,903 shares
|
-$153,206,917 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
8.1%
|
$507,739,457
4,180,646 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
Company
|
7.3%
|
$460,408,328
3,790,929 shares
|
— | 30 Sep 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.6%
|
$162,082,313
1,334,560 shares
|
— | 30 Sep 2025 |
| MACQUARIE GROUP LTD |
13F
Company
|
2.1%
|
$131,717,000
1,084,536 shares
|
— | 30 Sep 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
2%
|
$125,999,000
1,037,448 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
398
Shares
37,608,367
Rows available
398
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
352
Q4 2025 holders
398
Holder diff
46
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|